.svg){kind=small}
Jun-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Market Insights Snapshot
In June 2026, Dosecann’s category mix concentrated in Capsules at 35.9% share and Oil at 34.8% share, with Vapor Pens at 25.1% and Topical at 4.2%. Year over year, Capsules fell 67.1% while Oil declined 30.9%, contrasted by a 13.3% increase in Vapor Pens and a 91.3% drop in Topical; month over month, Capsules slipped 4.9% and Oil was essentially flat at -0.1%, while Vapor Pens rose 4.2% and Topical jumped 49.5%. The average price fell 8.4% year over year to $27.61, with category-level pricing spread from $22.60 in Oil to $40.51 in Topical, suggesting mix-driven pricing pressure tied to the heavier weight of lower-priced Oil. The pattern implies Dosecann is pivoting from legacy ingestibles toward inhalable formats, as stability in Oil and growth in Vapor Pens offset deep declines in Capsules and Topical.
These shifts imply a reorientation of positioning from wellness-led formats toward faster-turn, price-sensitive formats: a 35.9% share in Capsules paired with a 67.1% year-over-year contraction pushes reliance toward Oil at 34.8% share and the expanding Vapor Pens at 25.1%. The 4.2% month-over-month lift in Vapor Pens alongside a near-flat Oil at -0.1% indicates near-term traction where price points are lower, consistent with the 8.4% brand-wide price decline, and points to value-seeking behavior consolidating around inhalables. With Oil ranked 9 in Alberta, the portfolio’s center of gravity is moving toward categories where mid-pack rank can be defended through price and assortment, implying a positioning that favors accessible inhalables over shrinking high-price niches.
Competitive Landscape
Dosecann sits at #9 in AB Oil in June 2026, unchanged year over year at #9 but down two positions from its #7 spot in March 2026; that flat YoY rank alongside a quarter-on-quarter slippage suggests lost relative momentum despite a prior peak. In contrast, NightNight advanced from #6 to #3 while growing sales by 22.97%, and MediPharm Labs held #1 even with a -39.45% YoY sales decline, indicating that Dosecann’s stable #9 is driven more by others’ mixed trajectories than by its own ascent. With Tweed steady at #2 on 0.63% YoY growth and Dosecann drifting from #7 in March 2026 to #9 in June 2026, the pattern implies Dosecann is anchored in the lower top 10 unless it captures share from faster risers like NightNight.
Notable Products
CBD:CBN 20:5 Omega Rapid NightCaps 30-Pack (600mg CBD, 150mg CBN) plunged 72.4% month over month to rank 10 in June 2026, while CBD Oil (30ml) rose 105.2% to hold rank 1, signaling a sharp split between core Oil demand and fringe sleep-oriented capsules. CBD 50 Capsules 30-Pack (1500mg CBD) declined 6.2% at rank 2 as CBD/THC Daily Relief Cream (1200mg CBD, 40mg THC, 60ml) jumped 49.6% at rank 8, indicating shifting wallet share toward non-ingestible relief formats despite Capsules still occupying three of the top ten slots. The combined Vapor Pens presence at ranks 3, 4, and 6 moved in mixed directions with +16.6% and +7.5% offsets against a -7.2% drop, implying trial-led volatility rather than a uniform trend. Together these moves imply Dosecann’s commercial direction is consolidating around high-velocity Oils with selective bets on Topicals, while rationalizing capsule SKUs that lack repeat pull.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
